Semnur Pharmaceuticals, Inc. Notes Payable, Current
Semnur Pharmaceuticals, Inc. (SMNR) had Notes Payable, Current of $2.11 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Notes Payable, Current
us-gaap:NotesPayableCurrent · last filed 2026-08-10
- 2026-06-30: Notes Payable, Current $2.11M.
- 2026-03-31: Notes Payable, Current $2.77M.
- 2025-12-31: Notes Payable, Current $3.52M.
- 2025-09-30: Notes Payable, Current $4.48M.
| Period end | Notes Payable, Current |
|---|---|
| 2026-06-30 | $2.11M 10-Q · filed 2026-08-10 |
| 2026-03-31 | $2.77M 10-Q · filed 2026-05-13 |
| 2025-12-31 | $3.52M 10-Q · filed 2026-08-10 |
| 2025-09-30 | $4.48M 10-Q · filed 2025-11-12 |
| 2024-12-31 | $0.00 S-1 · filed 2026-05-12 |
| 2023-06-30 | $412.50K 10-Q · filed 2023-08-15 |